Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
TH.TO Stock Summary
Top 10 Correlated ETFs
TH.TO
In the News
TH.TO Financial details
Company Rating
Neutral
Market Cap
52.52M
Income
-29.13M
Revenue
79.73M
Book val./share
-1.72
Cash/share
0.95
Dividend
-
Dividend %
-
Employees
144
Optionable
No
Shortable
Yes
Earnings
26 Feb 2024
P/E
-1.33
Forward P/E
-3.74
PEG
2.84
P/S
0.48
P/B
-0.93
P/C
2.28
P/FCF
-3.81
Quick Ratio
0.33
Current Ratio
0.42
Debt / Equity
-1.4
LT Debt / Equity
-0.02
-
-
EPS (TTM)
-0.32
EPS next Y
-0.58
EPS next Q
-0.12
EPS this Y
47.06%
EPS next Y
78.96%
EPS next 5Y
78.96%
EPS last 5Y
53.02%
Revenue last 5Y
12.67%
Revenue Q/Q
18.84%
EPS Q/Q
-69.2%
-
-
-
-
SMA20
35.8%
SMA50
-21.71%
SMA100
-51.75%
Inst Own
0%
Inst Trans
0%
ROA
-51%
ROE
84%
ROC
0.46%
Gross Margin
74%
Oper. Margin
-24%
Profit Margin
-37%
Payout
-
Shs Outstand
24.2M
Shs Float
14.52M
-
-
-
-
Target Price
-
52W Range
1.22-6.48
52W High
-63.83%
52W Low
+117%
RSI
54.1
Rel Volume
0.25
Avg Volume
84.46K
Volume
21.4K
Perf Week
-3.56%
Perf Month
61.94%
Perf Quarter
-56.94%
Perf Half Y
-57.95%
-
-
-
-
Beta
1.606
-
-
Volatility
0.05%, 0.31%
Prev Close
0.93%
Price
2.17
Change
0.46%
TH.TO Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-11-30
Metric | History | 2018-11-30 | 2019-11-30 | 2020-11-30 | 2021-11-30 | 2022-11-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.58 | 0.82 | 0.86 | 0.76 | 0.84 | |
Net income per share | -0.06 | -0.23 | -0.29 | -0.34 | -0.5 | |
Operating cash flow per share | 0 | -0.04 | -0.18 | -0.16 | -0.15 | |
Free cash flow per share | 0 | -0.09 | -0.18 | -0.16 | -0.16 | |
Cash per share | 0.64 | 0.53 | 0.27 | 0.44 | 0.35 | |
Book value per share | 0.46 | 0.32 | 0.04 | 0.19 | -0.24 | |
Tangible book value per share | 0.26 | -0.19 | -0.37 | -0.07 | -0.39 | |
Share holders equity per share | 0.46 | 0.32 | 0.04 | 0.19 | -0.24 | |
Interest debt per share | 0.68 | 0.99 | 0.79 | 0.68 | 0.77 | |
Market cap | 1.88B | 940.77M | 713.8M | 1.21B | 830.84M | |
Enterprise value | 1.89B | 962.85M | 756.45M | 1.25B | 873.69M | |
P/E ratio | -414.34 | -53.8 | -31.49 | -38.26 | -17.59 | |
Price to sales ratio | 42.55 | 14.88 | 10.81 | 17.38 | 10.38 | |
POCF ratio | -5.61K | -277.43 | -52.66 | -83.85 | -56.55 | |
PFCF ratio | -5.02K | -134.15 | -52.54 | -82.89 | -53 | |
P/B Ratio | 53.53 | 37.88 | 221.4 | 68.35 | -36.81 | |
PTB ratio | 53.53 | 37.88 | 221.4 | 68.35 | -36.81 | |
EV to sales | 42.78 | 15.23 | 11.45 | 17.9 | 10.91 | |
Enterprise value over EBITDA | 1.87K | 24.07K | -82.42 | -76.59 | -32.17 | |
EV to operating cash flow | -5.64K | -283.94 | -55.81 | -86.36 | -59.47 | |
EV to free cash flow | -5.05K | -137.3 | -55.68 | -85.38 | -55.73 | |
Earnings yield | 0 | -0.02 | -0.03 | -0.03 | -0.06 | |
Free cash flow yield | 0 | -0.01 | -0.02 | -0.01 | -0.02 | |
Debt to equity | 1.41 | 2.87 | 17.18 | 3.2 | -2.96 | |
Debt to assets | 0.44 | 0.61 | 0.55 | 0.48 | 0.72 | |
Net debt to EBITDA | 10.16 | 552 | -4.65 | -2.23 | -1.58 | |
Current ratio | 2.74 | 2.05 | 1.55 | 2.04 | 0.64 | |
Interest coverage | -1.38 | -1.49 | -3.35 | -4.46 | -6.14 | |
Income quality | 0.07 | 0.27 | 0.6 | 0.46 | 0.31 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.13 | 0.13 | 0.19 | 0.21 | 0.22 | |
Research and developement to revenue | 0.18 | 0.17 | 0.27 | 0.4 | 0.46 | |
Intangibles to total assets | 0.14 | 0.34 | 0.32 | 0.2 | 0.16 | |
Capex to operating cash flow | 0.12 | 1.07 | 0 | 0.01 | 0.07 | |
Capex to revenue | 0 | -0.06 | 0 | 0 | -0.01 | |
Capex to depreciation | -0.01 | -0.48 | 0 | -0.02 | -0.08 | |
Stock based compensation to revenue | 0.02 | 0.02 | 0.02 | 0.03 | 0.05 | |
Graham number | 0.79 | 1.28 | 0.53 | 1.22 | 1.63 | |
ROIC | -0.03 | -0.11 | -0.29 | -0.33 | -0.87 | |
Return on tangible assets | -0.05 | -0.22 | -0.33 | -0.33 | -0.6 | |
Graham Net | -0.18 | -0.44 | -0.7 | -0.42 | -0.67 | |
Working capital | 46.79M | 39.04M | 22.89M | 46.83M | -40.91M | |
Tangible asset value | 19.92M | -14.85M | -28.63M | -6.07M | -37.58M | |
Net current asset value | -2.5M | -16.54M | -32.11M | -9.54M | -42.46M | |
Invested capital | 1.41 | 2.87 | 17.18 | 3.2 | -2.96 | |
Average receivables | 9.27M | 10.54M | 11.65M | 12.06M | 11.64M | |
Average payables | 10.51M | 14.35M | 15.31M | 16.52M | 14.21M | |
Average inventory | 9.18M | 16.01M | 23.04M | 27.14M | 24.41M | |
Days sales outstanding | 90.76 | 58.41 | 72.86 | 57.13 | 56.28 | |
Days payables outstanding | 439.02 | 183.45 | 237.57 | 243.64 | 178.98 | |
Days of inventory on hand | 312.26 | 292.95 | 341.16 | 457.29 | 273.45 | |
Receivables turnover | 4.02 | 6.25 | 5.01 | 6.39 | 6.49 | |
Payables turnover | 0.83 | 1.99 | 1.54 | 1.5 | 2.04 | |
Inventory turnover | 1.17 | 1.25 | 1.07 | 0.8 | 1.33 | |
ROE | -0.13 | -0.7 | -7.03 | -1.79 | 2.09 | |
Capex per share | 0 | -0.05 | 0 | 0 | -0.01 |
Quarterly Fundamentals Overview
Last date of statement is 2023-08-31 for Q3
Metric | History | 2022-08-31 | 2022-11-30 | 2023-02-28 | 2023-05-31 | 2023-08-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.22 | 0.23 | 0.21 | 0.18 | 0.86 | |
Net income per share | -0.08 | -0.08 | -0.11 | -0.1 | -0.03 | |
Operating cash flow per share | -0.01 | -0.09 | -0.03 | -0.04 | 0.22 | |
Free cash flow per share | -0.02 | -0.09 | -0.04 | -0.04 | 0.22 | |
Cash per share | 0.38 | 0.35 | 0.3 | 0.26 | 0.95 | |
Book value per share | -0.19 | -0.24 | -0.33 | -0.43 | -1.72 | |
Tangible book value per share | -0.19 | -0.4 | -0.33 | -0.43 | -1.72 | |
Share holders equity per share | -0.19 | -0.24 | -0.33 | -0.43 | -1.72 | |
Interest debt per share | 0.71 | 0.72 | 0.71 | 0.71 | 2.52 | |
Market cap | 842.01M | 829.77M | 367.54M | 345.58M | 22.11M | |
Enterprise value | 885.03M | 872.63M | 413.5M | 395.3M | 65.38M | |
P/E ratio | -27.88 | -26.16 | -8.8 | -8.63 | -7.41 | |
Price to sales ratio | 40.46 | 38.74 | 18.46 | 19.69 | 1.06 | |
POCF ratio | -704.02 | -100.65 | -110.07 | -97.02 | 4.15 | |
PFCF ratio | -464.94 | -100.4 | -103.21 | -94.86 | 4.16 | |
P/B Ratio | -46.62 | -36.76 | -11.37 | -8.32 | -0.53 | |
PTB ratio | -46.62 | -36.76 | -11.37 | -8.32 | -0.53 | |
EV to sales | 42.53 | 40.74 | 20.77 | 22.53 | 3.14 | |
Enterprise value over EBITDA | -192.06 | -189.45 | -97.04 | -58.06 | 60.32 | |
EV to operating cash flow | -739.99 | -105.85 | -123.84 | -110.98 | 12.27 | |
EV to free cash flow | -488.7 | -105.58 | -116.12 | -108.51 | 12.3 | |
Earnings yield | -0.01 | -0.01 | -0.03 | -0.03 | -0.03 | |
Free cash flow yield | 0 | -0.01 | -0.01 | -0.01 | 0.24 | |
Debt to equity | -3.68 | -2.96 | -2.04 | -1.61 | -1.4 | |
Debt to assets | 0.69 | 0.72 | 0.83 | 0.97 | 1.03 | |
Net debt to EBITDA | -9.34 | -9.3 | -10.79 | -7.3 | 39.92 | |
Current ratio | 1.05 | 0.64 | 0.84 | 0.72 | 0.42 | |
Interest coverage | -3.57 | -2.53 | -2.33 | -3.2 | 0.02 | |
Income quality | 0.16 | 1.04 | 0.32 | 0.36 | -7.14 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.2 | 0.18 | 0.22 | 0.21 | 0.18 | |
Research and developement to revenue | 0.4 | 0.44 | 0.47 | 0.59 | 0.26 | |
Intangibles to total assets | 0.13 | 0.16 | 0.18 | 0.2 | 0.23 | |
Capex to operating cash flow | 0.51 | 0 | 0.07 | 0.02 | 0 | |
Capex to revenue | -0.03 | 0 | -0.01 | 0 | 0 | |
Capex to depreciation | -0.72 | -0.02 | -0.24 | -0.09 | -0.02 | |
Stock based compensation to revenue | 0.04 | 0.04 | 0.03 | 0.04 | 0.02 | |
Graham number | 0.58 | 0.67 | 0.9 | 1 | 1.09 | |
ROIC | -0.11 | -0.13 | -0.16 | -0.31 | 0 | |
Return on tangible assets | -0.09 | -0.1 | -0.16 | -0.18 | -0.02 | |
Graham Net | -0.6 | -0.67 | -0.69 | -0.72 | -2.7 | |
Working capital | 3.38M | -40.91M | -12.01M | -20.19M | -57.09M | |
Tangible asset value | -30.91M | -37.58M | -46.58M | -55.06M | -54.56M | |
Net current asset value | -36.04M | -42.46M | -50.62M | -59.14M | -57.83M | |
Invested capital | -3.68 | -2.96 | -2.04 | -1.61 | -1.4 | |
Average receivables | 12.19M | 11.94M | 11.36M | 11.99M | 11.36M | |
Average payables | 42.32M | 26.98M | 23.48M | 33.84M | 32.03M | |
Average inventory | 24.06M | 21.41M | 17.4M | 12.14M | 7.94M | |
Days sales outstanding | 49.86 | 51.86 | 46.94 | 69.76 | 39.34 | |
Days payables outstanding | 698.57 | 196.27 | 653.63 | 616.1 | 551.87 | |
Days of inventory on hand | 393.55 | 299.87 | 289.77 | 167.97 | 121.82 | |
Receivables turnover | 1.8 | 1.74 | 1.92 | 1.29 | 2.29 | |
Payables turnover | 0.13 | 0.46 | 0.14 | 0.15 | 0.16 | |
Inventory turnover | 0.23 | 0.3 | 0.31 | 0.54 | 0.74 | |
ROE | 0.42 | 0.35 | 0.32 | 0.24 | 0.02 | |
Capex per share | -0.01 | 0 | 0 | 0 | 0 |
TH.TO Frequently Asked Questions
What is Theratechnologies Inc. stock symbol ?
Theratechnologies Inc. is a CA stock , located in Montreal of Qc and trading under the symbol TH.TO
What is Theratechnologies Inc. stock quote today ?
Theratechnologies Inc. stock price is $2.17 today.
Is Theratechnologies Inc. stock public?
Yes, Theratechnologies Inc. is a publicly traded company.